Gene Therapy Market Size, Share & Industry Analysis by Product (Zolgensma, Luxturna, Roctavian, and Others), By Vector Type (Viral Vectors and Non-Viral Vectors), By Indication (Genetic Disorders, Ophthalmology, Hematology, and Others), By End User (Hospitals & Clinics, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI100243

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Development of Gene Therapy for New Disease Indications
2. Regulatory Scenarios, By Key Countries/Regions
3. Technological Advancements in Gene Therapy Market
4. New Product Launches, By Key Players
5. Pipeline Analysis, By Key Companies
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
7. Pricing & Reimbursement Landscape in the Gene Therapy Market
8. Manufacturing & Supply Chain Insights
9. Investment & Funding Trends in the Market
10. Patient Access to the Therapy & Ethical Considerations
Global Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of the Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)
  1. Novartis AG
  2. F. Hoffmann-La Roche Ltd
  3. BioMarin Pharmaceutical Inc.
  4. CSL
  5. Vertex Pharmaceuticals Incorporated
  6. Krystal Biotech, Inc.
  7. Rocket Pharmaceuticals
  8. Dyno Therapeutics, Inc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Development of Gene Therapy for New Disease Indications
2. Regulatory Scenarios, By Key Countries/Regions
3. Technological Advancements in Gene Therapy Market
4. New Product Launches, By Key Players
5. Pipeline Analysis, By Key Companies
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
7. Pricing & Reimbursement Landscape in the Gene Therapy Market
8. Manufacturing & Supply Chain Insights
9. Investment & Funding Trends in the Market
10. Patient Access to the Therapy & Ethical Considerations
Global Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Gene Therapy Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Zolgensma
  2. Luxturna
  3. Roctavian
  4. Others
2. Market Analysis, Insights and Forecast – By Vector Type
  1. Viral Vectors
  2. Non-Viral Vectors
3. Market Analysis, Insights and Forecast – By Indication
  1. Genetic Disorders
  2. Ophthalmology
  3. Hematology
  4. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of the Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)
  1. Novartis AG
  2. F. Hoffmann-La Roche Ltd
  3. BioMarin Pharmaceutical Inc.
  4. CSL
  5. Vertex Pharmaceuticals Incorporated
  6. Krystal Biotech, Inc.
  7. Rocket Pharmaceuticals
  8. Dyno Therapeutics, Inc.

Read Less

List of Figures

Figure 1: Global Gene Therapy Market Revenue Breakdown (USD Billion, %) by Region, 2024 & 2032

Figure 2: Global Gene Therapy Market Value Share (%), By Product, 2024 & 2032

Figure 3: Global Gene Therapy Market Value Share (%), By Vector Type, 2024 & 2032

Figure 4: Global Gene Therapy Market Value Share (%), By Indication, 2024 & 2032

Figure 5: Global Gene Therapy Market Value Share (%), By End User, 2024 & 2032

Figure 6: Global Gene Therapy Market Value (USD Billion), by Region, 2024 & 2032

Figure 7: North America Gene Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 8: North America Gene Therapy Market Value Share (%), By Product, 2024

Figure 9: North America Gene Therapy Market Value (USD Billion), By Vector Type, 2024 & 2032

Figure 10: North America Gene Therapy Market Value Share (%), By Vector Type, 2024

Figure 11: North America Gene Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 12: North America Gene Therapy Market Value Share (%), By Indication, 2024

Figure 13: North America Gene Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 14: North America Gene Therapy Market Value Share (%), By End User, 2024

Figure 15: North America Gene Therapy Market Value (USD Billion), By Country, 2024 & 2032

Figure 16: North America Gene Therapy Market Value Share (%), By Country, 2024

Figure 17: Europe Gene Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 18: Europe Gene Therapy Market Value Share (%), By Product, 2024

Figure 19: Europe Gene Therapy Market Value (USD Billion), By Vector Type, 2024 & 2032

Figure 20: Europe Gene Therapy Market Value Share (%), By Vector Type, 2024

Figure 21: Europe Gene Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 22: Europe Gene Therapy Market Value Share (%), By Indication, 2024

Figure 23: Europe Gene Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 24: Europe Gene Therapy Market Value Share (%), By End User, 2024

Figure 25: Europe Gene Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Gene Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Gene Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 28: Asia Pacific Gene Therapy Market Value Share (%), By Product, 2024

Figure 29: Asia Pacific Gene Therapy Market Value (USD Billion), By Vector Type, 2024 & 2032

Figure 30: Asia Pacific Gene Therapy Market Value Share (%), By Vector Type, 2024

Figure 31: Asia Pacific Gene Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 32: Asia Pacific Gene Therapy Market Value Share (%), By Indication, 2024

Figure 33: Asia Pacific Gene Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 34: Asia Pacific Gene Therapy Market Value Share (%), By End User, 2024

Figure 35: Asia Pacific Gene Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Gene Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America Gene Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 38: Latin America Gene Therapy Market Value Share (%), By Product, 2024

Figure 39: Latin America Gene Therapy Market Value (USD Billion), By Vector Type, 2024 & 2032

Figure 40: Latin America Gene Therapy Market Value Share (%), By Vector Type, 2024

Figure 41: Latin America Gene Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 42: Latin America Gene Therapy Market Value Share (%), By Indication, 2024

Figure 43: Latin America Gene Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 44: Latin America Gene Therapy Market Value Share (%), By End User, 2024

Figure 45: Latin America Gene Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America Gene Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa Gene Therapy Market Value (USD Billion), By Product, 2024 & 2032

Figure 48: Middle East & Africa Gene Therapy Market Value Share (%), By Product, 2024

Figure 49: Middle East & Africa Gene Therapy Market Value (USD Billion), By Vector Type, 2024 & 2032

Figure 50: Middle East & Africa Gene Therapy Market Value Share (%), By Vector Type, 2024

Figure 51: Middle East & Africa Gene Therapy Market Value (USD Billion), By Indication, 2024 & 2032

Figure 52: Middle East & Africa Gene Therapy Market Value Share (%), By Indication, 2024

Figure 53: Middle East & Africa Gene Therapy Market Value (USD Billion), By End User, 2024 & 2032

Figure 54: Middle East & Africa Gene Therapy Market Value Share (%), By End User, 2024

Figure 55: Middle East & Africa Gene Therapy Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa Gene Therapy Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global Gene Therapy Market Share (%), By Company, 2024

List of Tables

Table 1: Global Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019–2032

Table 2: Global Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019–2032

Table 3: Global Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 4: Global Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019–2032

Table 5: Global Gene Therapy Market Revenue (USD Billion) Forecast, by Region, 2019-2032

Table 6: North America Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 7: North America Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019-2032

Table 8: North America Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 9: North America Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 10: North America Gene Therapy Market Revenue (USD Billion) Forecast, By Country, 2019-2032

Table 11: Europe Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 12: Europe Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019-2032

Table 13: Europe Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 14: Europe Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 15: Europe Gene Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 17: Asia Pacific Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019-2032

Table 18: Asia Pacific Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 19: Asia Pacific Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 20: Asia Pacific Gene Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 22: Latin America Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019-2032

Table 23: Latin America Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 24: Latin America Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 25: Latin America Gene Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Gene Therapy Market Revenue (USD Billion) Forecast, By Product, 2019-2032

Table 27: Middle East & Africa Gene Therapy Market Revenue (USD Billion) Forecast, By Vector Type, 2019-2032

Table 28: Middle East & Africa Gene Therapy Market Revenue (USD Billion) Forecast, By Indication, 2019–2032

Table 29: Middle East & Africa Gene Therapy Market Revenue (USD Billion) Forecast, By End User, 2019-2032

Table 30: Middle East & Africa Gene Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 167

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Regenerative Medicine Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com